California State Teachers Retirement System (CalSTRS)’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
California State Teachers Retirement System (CalSTRS)'s SMMT Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Summit Therapeutics (SMMT) stake by 70% in Q2 2026, selling an estimated $79.5K and leaving 1,907 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2256.
California State Teachers Retirement System (CalSTRS) first reported a position in SMMT in Q2 2021 and has held it in 17 quarters since. The position peaked at $570K in Q1 2024. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) held 1,907 shares of Summit Therapeutics worth $27.8K as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) sold 4,484 Summit Therapeutics shares in Q2 2026, an estimated $79.5K.
- Summit Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2256 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Summit Therapeutics in Q2 2021 and has held it in 17 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Summit Therapeutics position peaked at $570K in Q1 2024.
- 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.